We found that GBM patients with low transcriptional levels of IGFBP4 (P=0.0075) and IGFBP6 (P=0.033) were significantly associated with longer overall survival (Figure 3), and we selected these for subsequent analysis. Here, IGFBP6 is linked to glioblastoma.